SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX) reports financial results for the first quarter ended March 31, 2009. These results highlight the Company’s progress and demonstrate commercial, clinical and strategic achievements, which year-to-date include:
